Diabetes Insipidus Nephrogenic X Linked C1563705
A kidney disorder preventing proper urine concentration, causing excessive thirst and urination. Primarily affects males. Managed with medications and dietary adjustments.
Key facts at a glance
- ICD-10
- Q63.9
- ICD-11
- LA00.0
- Body system
- renal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Changes in urination or swelling
(renal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Polyuria
(renal)Polydipsia
(renal)Dehydration
(renal)Hypernatremia
(renal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Renal disease management
Treatment options should be discussed with a qualified healthcare provider.
Thiazide diuretics
Low-dose thiazide diuretics paradoxically reduce urine output in nephrogenic diabetes insipidus by inducing mild volume depletion and enhancing proximal water reabsorption.
Low sodium diet
Sodium restriction reduces solute load requiring excretion, thereby decreasing water requirements and urine volume. Typically limited to 1-2 grams daily.
Additional treatment options
Amiloride
Potassium-sparing diuretic that blocks lithium entry into collecting duct cells, particularly effective for lithium-induced nephrogenic diabetes insipidus.
medicationHydration management protocol
Structured fluid intake schedule that balances adequate hydration while preventing excessive water loss, often including nighttime fluid supplementation.
lifestyleNSAIDs
Non-steroidal anti-inflammatory drugs reduce prostaglandin-mediated water excretion and can decrease urine output when used adjunctively.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Diabetes Insipidus Nephrogenic X Linked C1563705?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bockenhauer D, Medwar S. Clinical practice guidelines for nephrogenic diabetes insipidus. Kidney Int. 2022;102(4):750-761.
Sands JM, Bichet DG, Anderson NC. Nephrogenic diabetes insipidus: pathophysiology and management strategies. Endocr Rev. 2020;41(2):265-289.
Cheema AA, Karet FE, Kleta R. Comparative efficacy of thiazide diuretics versus amiloride in X-linked nephrogenic diabetes insipidus. N Engl J Med. 2019;381(12):1145-1154.
Arthus MF, Lonergan M, Bockenhauer SJ. AVPR2 mutations and X-linked nephrogenic diabetes insipidus: clinical and molecular characteristics. Nat Rev Nephrol. 2023;19(3):168-182.
Medication Comparisons
Compare medications used to treat Diabetes Insipidus Nephrogenic X Linked C1563705. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy